Decision-making in polydrug amphetamine-type stimulant users: an fMRI study

Area of Science:

• Neuroscience
• Psychopharmacology
• Cognitive Science

Background:

• Stimulant drug use, including amphetamine and MDMA, is linked to impaired decision-making and altered brain activation.
• Decision-making deficits may stem from prioritizing short-term rewards over long-term consequences, fostering rigid stimulus-response behaviors.

Purpose of the Study:

• To investigate decision-making processes and associated neural activation patterns in individuals with varying exposure to amphetamine and MDMA.
• To compare functional magnetic resonance imaging (fMRI) activation between experienced users, low-exposure users, and drug-naive controls during a risky decision-making task.

Main Methods:

• Utilized a functional magnetic resonance imaging (fMRI) study to assess brain activity during a risky choice paradigm.
• Participants made choices between a low-risk control gamble and an experimental gamble with varying probabilities and monetary outcomes.
• Behavioral performance and neural activation were analyzed across three groups: experienced users (EU), low-exposure users, and drug-naive controls.

Main Results:

• No significant differences in behavioral decision-making performance were observed between the experienced users, low-exposure users, and drug-naive controls.
• Anticipation of reward activated the frontal cortex and striatum in low-exposure users and controls, while frontal and parietal regions were activated in all groups upon outcome presentation.
• Experienced users exhibited greater activation in response to a high probability of winning compared to control groups.

Conclusions:

• Neuronal activation patterns can differ between drug users and healthy individuals even in the absence of observable behavioral deficits.
• In experienced stimulant users, the probability of an event significantly influences neural activation more than the magnitude of potential rewards.